Hunan Er-Kang Pharmaceutical (300267.SZ) Earnings Analysis
Hunan Er-Kang Pharmaceutical (300267.SZ) has no confirmed upcoming earnings date. Trailing P/E -16.06.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300267.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 300267.SZ. This page updates as the calendar is published.
300267.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-29 | 0.00094 CNY | n/a | n/a | n/a |
| 2025-06-30 | 0.00461 CNY | n/a | n/a | n/a |
| 2025-05-16 | -0.16848 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.0136 CNY | n/a | n/a | n/a |
| 2024-09-28 | -0.0154 CNY | n/a | n/a | n/a |
300267.SZ valuation and analyst view
| Trailing P/E | -16.06 |
|---|---|
| Trailing EPS | -0.19142 CNY |
| Price / book | 1.55 |
| Dividend yield | 0.00% |
| Market cap | 6.00B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Hunan Er-Kang Pharmaceutical (300267.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 300267.SZ. This page updates as the calendar is published.
Did 300267.SZ beat earnings last quarter?
Consensus estimate data was not available for 300267.SZ's 2025-09-29 report.
What is 300267.SZ's current P/E ratio and EPS?
300267.SZ trades at a trailing P/E of -16.06 on trailing EPS of -0.1914189357072545 CNY.
What do analysts rate 300267.SZ?
300267.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.